Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV)

Vaccine

Volumn 16, Issue 17, 1998, Pages 1656-1659

  Dietzschold, Bernhard ^a   Hooper, D Craig ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bat rabies virus; Human rabies vaccines; Protective immunity

Indexed keywords

DIPLOID CELL VACCINE; NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BAT; CELL CULTURE; CLINICAL TRIAL; CONTROLLED STUDY; DOG; DRUG FORMULATION; DRUG POTENCY; EMBRYO CELL; HUMAN; HUMAN EXPERIMENT; IMMUNITY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; RABIES VIRUS; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; CELL CULTURE TECHNIQUES; CHICK EMBRYO; CHIROPTERA; DOGS; FEMALE; HUMANS; IMMUNIZATION; MICE; RABIES VACCINES;

EID: 0032192575     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00064-4     Document Type: Article

References (17)

1. 1 Dietzschold, B., Rupprecht, C.E., Fu, Z.F. and Koprowski, H. Rhabdoviruses, In: Fields Virology, 3rd edn, Field, B.N., Knipe, D.M. and Howly, P.M. (Eds.). Lippincott-Raven, Philadelphia, 1996, pp. 1137-1159.
2. 2 Centers for Disease Control and Prevention. Morbid. Mortal. Wkly Rep. 1993, 42, 805-806.
3. 3 Centers for Disease Control and Prevention. Morbid. Mortal. Wkly Rep. 1995, 44, 269-272.
4. 4 Warrell, M.J. Human deaths from cryptic bat rabies in the USA. Lancet 1995, 346, 65-66.
5. 5 Rupprecht, C.E., Smith, J.S., Fekadu, M. and Childs, J.E. The ascension of wildlife rabies: a cause for public health concern or intervention?. Emerg. Infect. Dis. 1995, 1, 107-114.
6. 6 Morimoto, K., Patel, M. and Corisdeo, S. et al. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc. Natl Acad. Sci. USA 1996, 83, 7949-7952.
7. 7 Dietzschold, B. and Ertl, H.C.J. New developments in the pre-and post-exposure treatment of rabies. Crit. Rev. Immunol. 1991, 10, 427-439.
8. 8 Sehgal, S., Bhattacharya, D. and Bhardwal, M. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre-and post-exposure prophylaxis of rabies in Indian population. J. Com. Dis. 1995, 27, 36-43.
9. 9 Centers for Disease Control and Prevention. Morbid. Mortal. Wkly Rep. 1994, 43, 455-457.
10. 10 Clark, K.A., Neil, S.U., Smith, J.S., Wilson, P.J., Whadford, V.W. and McKirahan, G.W. Epizootic canine rabies transmitted by coyotes in South Texas. J. Am. Vet. Assoc. 1994, 204, 536-540.
11. 11 Habel, K. Habel test for potency. In: Laboratory Techniques in Rabies, Meslin, F.-X., Kaplan, M.M. and Koprowski, H. (eds.). World Health Organization, Geneva, 1996, Ch. 38, pp. 369-373.
12. 12 Dreesen, D.W. and Briggs, D.J. Comparison of one or two dose simulated post-exposure immunization with purified chick embryo cell rabies vaccine (PCECV) given one year after a primary immunization series with PCECV or human dipfoid cell rabies vaccine (HDCV). In preparation.
13. 13 Wilbur, L.A. and Aubert, M.F.A. The NIH test for potency. In: Laboratory Techniques in Rabies, Meslin, F.-X., Kaplan, M.M. and Koprowski, H. (Eds.). World Health Organization, Geneva, 1996, Ch. 37, pp. 360-368.
14. 14 Wiktor, T.J., MacFarlan, R.I., Foggin, C.M. and Koprowski, H. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies. Dev. Biol. Stand. 1984, 57, 199-211.
15. 15 Dietzschold, B., Tollis, M., Rupprecht, C.E., Celis, E. and Koprowski, H. Antigenic variation in rabies and rabies related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. J. Infect. Dis. 1987, 156, 815-822.
16. 16 Dietzschold, B., Rupprecht, C.E., Tollis, M., Lafon, M., Wiktor, T.J. and Koprowski, H. Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev. Infect. Dis. 1988, 10, 785-797.
17. 17 Dietzschold, B., Kao, M. and Zheng, Y.M. et al. Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc. Natl Acad. Sci. 1992, 89, 7252-7256.